SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
296.40    11.00 (3.85%)
Bid:
296.20
Ask:
296.40
Spread: 0.20 (0.068%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

18 May 2023 16:52

RNS Number : 9444Z
Breedon Group PLC
18 May 2023
 

18 May 2023

Breedon Group plc (the "Company")

Directors' and PDMRs' Dealings

 

The Company announces that, on 16 May 2023, certain persons discharging managerial responsibilities were granted rollover conditional share awards under the terms of the Breedon PSPs and rollover options under the terms of the Breedon UK SAYE Plans, in each case in respect of ordinary shares of £1.40 each in the capital of the Company. These grants were undertaken in accordance with the procedures set out in the prospectus published by the Company on 11 May 2023 (the "Prospectus") and the scheme document published by Breedon Group plc (a company incorporated in Jersey with registered number 98465) on 29 March 2023 (the "Scheme Document").

The exercise price for each rollover option granted under the Breedon UK SAYE Plans is set out below. The rollover options are generally exercisable at any time within six months following the maturity of the relevant SAYE contract. The rollover conditional share awards granted under the terms of the Breedon PSPs are "nil-cost" awards and are subject to the same vesting terms and performance conditions as applied to the preceding conditional share awards that they replace. Further information in relation to these arrangements can be found in the Prospectus and the Scheme Document.

Defined terms used in this announcement have the meanings ascribed to them in the Prospectus, unless otherwise stated.

 

Enquiries:

 

Breedon Group plc www.breedongroup.com 

James Atherton-Ham, Group General Counsel +44 (0) 1332 694010

Louise Turner-Smith, Head of Investor Relations +44 (0) 7860 911909

 

MHP (Public Relations Adviser)  +44 (0) 20 3128 8193

Reg Hoare

Rachel Farrington

Charles Hirst

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rob Wood

2

Reason for Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary Shares of £1.40 each

Identification code

 

GB00BM8NFJ84

 

b)

Nature of the transaction

Grant of the following rollover conditional share awards and options in connection with the Scheme:

 

1. Rollover 2020 Breedon PSP award

 

2. Rollover 2021 Breedon PSP award

 

3. Rollover 2022 Breedon PSP award

 

4. Rollover 2023 Breedon PSP award

 

5. Rollover 2019 5yr Breedon UK SAYE Plan option

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

 

2. Nil

 

3. Nil

 

4. Nil

 

5. £2.75

 

1. 131,410

 

2. 171,812

 

3. 229,477

 

4. 271,552

 

5. 10,909

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Total Aggregate Volume

N/a

815,160

815,160

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

London Stock Exchange plc

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Brotherton

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary Shares of £1.40 each

Identification code

 

GB00BM8NFJ84

 

b)

Nature of the transaction

Grant of the following rollover conditional share awards and options in connection with the Scheme:

 

1. Rollover 2021 Breedon PSP award

 

2. Rollover 2022 Breedon PSP award

 

3. Rollover 2023 Breedon PSP award

 

4. Rollover 2021 5yr Breedon UK SAYE Plan option

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. Nil

 

2. Nil

 

3. Nil

 

4. £3.56

 

 

1. 99,601

 

2. 155,223

 

3. 183,684

 

4. 8,426

d)

Aggregated information

- Aggregated volume

- Price

Aggregate Price

Aggregate Volume

Total Aggregate Volume

N/a

446,934

446,934

e)

Date of the transaction

16 May 2023

f)

Place of the transaction

London Stock Exchange plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFFFIAEDSEII
Date   Source Headline
9th Jun 20267:00 amRNSAcquisition
13th May 20265:41 pmRNSDirector/PDMR Shareholding
12th May 20262:03 pmRNSHolding(s) in Company
30th Apr 20263:14 pmRNSTotal Voting Rights
29th Apr 20265:01 pmRNSResult of AGM
29th Apr 20267:00 amRNSAGM Trading Update
16th Apr 20264:40 pmRNSDirector/PDMR Shareholding
14th Apr 20265:10 pmRNSDirector/PDMR Shareholding
10th Apr 20269:55 amRNSHolding(s) in Company
9th Apr 20263:29 pmRNSDirector/PDMR Shareholding
9th Apr 20269:07 amRNSHolding(s) in Company
8th Apr 20263:41 pmRNSDirector/PDMR Shareholding
7th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 20269:48 amRNS-RBacking British Cement
31st Mar 20262:08 pmRNSTotal Voting Rights
24th Mar 20264:36 pmRNSHolding(s) in Company
23rd Mar 20262:05 pmRNSHolding(s) in Company
23rd Mar 20262:04 pmRNSHolding(s) in Company
23rd Mar 202612:01 pmRNS2025 Annual Report and Notice of AGM
19th Mar 20269:20 amRNSHolding(s) in Company
18th Mar 202610:41 amRNSHolding(s) in Company
16th Mar 202611:43 amRNSHolding(s) in Company
11th Mar 202611:39 amRNS-RBacking British Cement
11th Mar 20267:00 amRNSFinal Results
4th Mar 20267:00 amRNS-RLive presentation via Investor Meet Company
27th Feb 20269:33 amRNSTotal Voting Rights
11th Feb 20264:01 pmRNSIssue of Shares
30th Jan 202612:44 pmRNSBlock Listing Update
30th Jan 20267:00 amRNSNotice of Annual Results 2025
31st Dec 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Dec 20257:00 amRNSTotal Voting Rights
2nd Dec 20253:49 pmRNSDirector/PDMR Shareholding
28th Nov 20253:29 pmRNSDirector/PDMR Shareholding
28th Nov 20258:55 amRNSTotal Voting Rights
26th Nov 20255:20 pmRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSTrading Update
12th Nov 20253:30 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSAppointment of Joint Corporate Broker
31st Oct 202510:43 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTotal Voting Rights
29th Aug 20254:17 pmRNSTotal Voting Rights
29th Aug 20253:51 pmRNSHolding(s) in Company
29th Aug 20253:46 pmRNSHolding(s) in Company
29th Aug 202512:18 pmRNSDirector/PDMR Shareholding
13th Aug 202511:13 amRNSDirector/PDMR Shareholding
31st Jul 20258:51 amRNSTotal Voting Rights
24th Jul 202510:03 amRNSDirector/PDMR Shareholding
24th Jul 202510:02 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSInterim Results 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.